IT1073893B - N-aril-n(piperidinil sostituito)-arilacetammidi e relativo procedimento di produzione - Google Patents

N-aril-n(piperidinil sostituito)-arilacetammidi e relativo procedimento di produzione

Info

Publication number
IT1073893B
IT1073893B IT51370/76A IT5137076A IT1073893B IT 1073893 B IT1073893 B IT 1073893B IT 51370/76 A IT51370/76 A IT 51370/76A IT 5137076 A IT5137076 A IT 5137076A IT 1073893 B IT1073893 B IT 1073893B
Authority
IT
Italy
Prior art keywords
arylacetamides
aril
production process
related production
substituted piperidinyl
Prior art date
Application number
IT51370/76A
Other languages
English (en)
Original Assignee
Jansenn Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jansenn Pharmaceutica Nv filed Critical Jansenn Pharmaceutica Nv
Application granted granted Critical
Publication of IT1073893B publication Critical patent/IT1073893B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT51370/76A 1975-09-23 1976-09-21 N-aril-n(piperidinil sostituito)-arilacetammidi e relativo procedimento di produzione IT1073893B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (1)

Publication Number Publication Date
IT1073893B true IT1073893B (it) 1985-04-17

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
IT51370/76A IT1073893B (it) 1975-09-23 1976-09-21 N-aril-n(piperidinil sostituito)-arilacetammidi e relativo procedimento di produzione

Country Status (29)

Country Link
JP (1) JPS6016417B2 (it)
AT (1) AT363935B (it)
AU (1) AU510029B2 (it)
BG (1) BG27543A3 (it)
CA (1) CA1068271A (it)
CH (1) CH628623A5 (it)
CS (1) CS222663B2 (it)
DE (1) DE2642856A1 (it)
DK (1) DK150478C (it)
ES (1) ES451768A1 (it)
FI (1) FI61482C (it)
FR (1) FR2325377A1 (it)
GB (1) GB1539473A (it)
GR (1) GR58469B (it)
HU (1) HU172964B (it)
IE (1) IE43802B1 (it)
IL (1) IL50522A (it)
IT (1) IT1073893B (it)
LU (1) LU75837A1 (it)
NL (1) NL187267C (it)
NO (1) NO147672C (it)
NZ (1) NZ181972A (it)
PH (1) PH12497A (it)
PL (2) PL117323B1 (it)
PT (1) PT65631B (it)
RO (1) RO70079A (it)
SE (1) SE427839B (it)
SU (1) SU747424A3 (it)
YU (1) YU39973B (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (ja) * 1986-05-08 1987-11-13 株式会社ヘキトク 燻瓦の製造ラインにおける焼成工程後の表面仕上げ装置
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
MX2009011415A (es) 2007-04-23 2009-11-05 Janssen Pharmaceutica Nv Derivados de 4-alcoxipiridazina como antagonistas del receptor de dopamina 2 de rapida disociacion.
RU2480462C2 (ru) * 2007-04-23 2013-04-27 Янссен Фармацевтика Н.В. Производные пиридина, используемые в качестве быстро диссоциирующихся антагонистов допаминовых рецепторов 2
JP5431306B2 (ja) 2007-04-23 2014-03-05 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 高速解離性ドパミン2受容体アンタゴニストとしてのチア(ジア)ゾール
RU2502734C2 (ru) 2008-07-03 2013-12-27 Янссен Фармацевтика Нв Замещенные 6-(1-пиперазинил)-пиридазины в качестве антагонистов 5-нт6 рецептора
JP5457450B2 (ja) 2008-07-31 2014-04-02 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 迅速解離性ドーパミン2受容体拮抗薬としてのピペラジン−1−イル−トリフルオロメチル−置換−ピリジン

Also Published As

Publication number Publication date
LU75837A1 (it) 1977-05-04
PL117323B1 (en) 1981-07-31
NL187267C (nl) 1991-08-01
NZ181972A (en) 1978-07-28
CS222663B2 (en) 1983-07-29
DE2642856A1 (de) 1977-03-24
SE427839B (sv) 1983-05-09
NL7610513A (nl) 1977-03-25
YU233676A (en) 1983-01-21
RO70079A (ro) 1982-10-26
DK150478B (da) 1987-03-09
HU172964B (hu) 1979-01-28
ATA702976A (de) 1981-02-15
CH628623A5 (en) 1982-03-15
BG27543A3 (en) 1979-11-12
NO147672C (no) 1983-05-25
FI61482B (fi) 1982-04-30
JPS6016417B2 (ja) 1985-04-25
NL187267B (nl) 1991-03-01
AU1787876A (en) 1978-03-23
IL50522A (en) 1979-09-30
FI762698A (it) 1977-03-24
PT65631B (en) 1978-07-05
PH12497A (en) 1979-04-05
NO147672B (no) 1983-02-14
PT65631A (en) 1976-10-01
YU39973B (en) 1985-06-30
ES451768A1 (es) 1978-05-01
IE43802B1 (en) 1981-06-03
PL192578A1 (pl) 1979-02-26
CA1068271A (en) 1979-12-18
DK150478C (da) 1987-10-05
DE2642856C2 (it) 1990-06-21
SE7610501L (sv) 1977-03-24
AT363935B (de) 1981-09-10
AU510029B2 (en) 1980-06-05
NO763054L (no) 1977-03-24
GB1539473A (en) 1979-01-31
IE43802L (en) 1977-03-23
GR58469B (en) 1977-10-14
JPS5239683A (en) 1977-03-28
FR2325377B1 (it) 1980-04-18
DK427876A (da) 1977-03-24
FI61482C (fi) 1982-08-10
SU747424A3 (ru) 1980-07-23
IL50522A0 (en) 1976-11-30
FR2325377A1 (fr) 1977-04-22

Similar Documents

Publication Publication Date Title
IT1069990B (it) Composizione candeggiante stabilizzata e relativo procedimento di produzione
IT1090325B (it) Composizioni glicoluriliche reticolanti e relativo procedimento di produzione
SE7608261L (sv) Gasframstellning
IT1061273B (it) Procedimento per la produzione di polibutilentereftalato
IT1058013B (it) Derivati della salicilanilde e relativo procedimento di produzione
PL191647A1 (pl) Sposob wytwarzania pochodnych tienopirydyny
IT1064624B (it) Procedimento di produzione di freddo
IT1073893B (it) N-aril-n(piperidinil sostituito)-arilacetammidi e relativo procedimento di produzione
IT1066087B (it) Composti polivinilici aromatici e relativo procedimento di produzione
IT1057943B (it) Processo per comporre gomma e relativo prodotto
IT1058596B (it) Processo di nichelatura
IT1106121B (it) Derivati 25-alchilcolesterolici e relativo procedimento di produzione
BR7602728A (pt) Composicao explosiva e processo para sua fabricacao
IT1195099B (it) Produzione di gas di sintesi
IT1061299B (it) Procedimento per la produzione 2 5 diclorotoluolo
BR7601921A (pt) Processo de producao de hidratos alcali-metalicos
IT1145379B (it) Cleomicine e relativo procedimento di produzione
IT1052654B (it) Indole sostituiti e relativo procedimento di produzione
IT1077484B (it) Composizione dolcificante e relativo procedimento di produzione
IT1066195B (it) Alcossisilani alogenati e relativo procedimento di produzione
IT1155821B (it) Imidazopiridazine sostituite e relativo procedimento di produzione
BR7608549A (pt) Processo para producao de metano
IT1121684B (it) Isossazoli e procedimento per la loro produzione
IT1079950B (it) 4-ossocapronitrile e relativo procedimento di produzione
IT1057413B (it) Dolcificante ionico e relativo procedimento di produzione